Enzyme replacement therapy and bony changes in Egyptian paediatric Gaucher disease patients.
about
Revised recommendations for the management of Gaucher disease in children.Long-term clinical outcomes in type 1 Gaucher disease following 10 years of imiglucerase treatmentDiagnosis features of pediatric Gaucher disease patients in the era of enzymatic therapy, a national-base study from the Spanish Registry of Gaucher Disease.Modelling Gaucher disease progression: long-term enzyme replacement therapy reduces the incidence of splenectomy and bone complications.Glycosphingolipid synthesis inhibition limits osteoclast activation and myeloma bone disease.Long-term follow-up and sudden unexpected death in Gaucher disease type 3 in Egypt.Timing of initiation of enzyme replacement therapy after diagnosis of type 1 Gaucher disease: effect on incidence of avascular necrosis.Glucosidase acid beta gene mutations in Egyptian children with Gaucher disease and relation to disease phenotypes.Recommendations for the assessment and monitoring of skeletal manifestations in children with Gaucher disease.Effect of glycosphingolipids on osteoclastogenesis and osteolytic bone diseases.Long-term effectiveness of enzyme replacement therapy in adults with Gaucher disease: results from the NCS-LSD cohort study.Risk factors for fractures and avascular osteonecrosis in type 1 Gaucher disease: a study from the International Collaborative Gaucher Group (ICGG) Gaucher Registry.
P2860
Q33402191-673F6AE4-3C17-417D-BBD5-44230B6177BFQ33403298-4CA00F4F-DF20-46D8-82B7-B608A152FFA9Q33634529-CF0087D0-03C8-4396-BEDD-2CBA4EA57D6DQ34485240-3CD4A923-7D74-40F4-8AD5-C9D502A502DEQ35899430-272960FF-8F77-49AB-8FDA-7A598D70C627Q36794105-3BFEE93B-7F23-46F9-B068-6DA1B6D2EA89Q37413920-D0410FF1-83E1-41D8-A442-561EDB055BE3Q38988854-4015644B-1018-41E6-B292-FDBD9D57C1DDQ41920513-588F9B4E-B05C-473E-AE50-6643E9943DF7Q42288514-71DEDA0F-BE52-405E-8536-E471E4D58725Q45284421-FB55C1CA-3408-4FD6-B548-FA3EF2280045Q53128627-0CD9FC92-F695-4DF0-8996-7EE88A9850FC
P2860
Enzyme replacement therapy and bony changes in Egyptian paediatric Gaucher disease patients.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Enzyme replacement therapy and ...... tric Gaucher disease patients.
@en
type
label
Enzyme replacement therapy and ...... tric Gaucher disease patients.
@en
prefLabel
Enzyme replacement therapy and ...... tric Gaucher disease patients.
@en
P2093
P2860
P1476
Enzyme replacement therapy and ...... tric Gaucher disease patients.
@en
P2093
Abd El-Hamid S
El-Beshlawy A
Mansour IM
P2860
P2888
P356
10.1007/S10545-006-0121-6
P577
2006-02-01T00:00:00Z
P6179
1035536925